Skip to content

ADMA BIOLOGICS, INC.

ADMA

CIK 0001368514

← back to feed
Revenue (TTM)
$485.5M
+19.6% YoY Q1 May 2026
Net Income (TTM)
$142.88M
−25.7% YoY Q1 May 2026
EPS Diluted (TTM)
$0.59
−25.9% YoY Q1 May 2026
Gross Margin
58.6%
Q1 May 2026
Operating Margin
38.5%
Q1 May 2026
Net Margin
29.4%
Q1 May 2026
Free Cash Flow (TTM)
$10.1M
Q1 May 2026
Cash
$138.15M
Q1 May 2026
Total Debt
$196.87M
Q1 May 2026
Shares Outstanding
231.77M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings